DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.

Contact Us

August 9, 2016

CorMedix Inc.
300 Connell Drive
Suite 4200
Berkeley Heights, NJ
TEL +1 908-517-9500
FAX +1 908-375-8272

For Investors & Media:
Dan Ferry
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
617-430-7576